Problemática actual en el diagnóstico diferencial de la hiperprolactinemia
Javier Salvador(Instituto de Salud Carlos III), Rachel Hall(Welsh Government), John A. Peters(University of Dundee), A Gómez-Pan(United States Nuclear Regulatory Commission), S.M. Foord(Welsh Government), MF Scanlon(Welsh Government), M. D. Rodríguez-Arnao(Welsh Government), E Moncada(Clinica Universidad de Navarra), Carlos Diéguez(Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition)
Cited by 0
Related Papers
Neurosteroids and GABAA receptor function
|Trends in Pharmacological Sciences|1995|743
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
|British Journal of Pharmacology|2017|597
A nomenclature for ligand-gated ion channels
|Neuropharmacology|2008|590
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein‐coupled receptors
|British Journal of Pharmacology|2017|589